[Usability of the electrodermatometric technic (Wohlstein) in pyrazolone derivative therapy].
D000962:Antimalarials / Q000009:adverse effects; D001452:Balneology; D003078:Colchicine / Q000009:adverse effects; D003095:Collagen Diseases / Q000139:chemically induced; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000517:prevention & control; D005712:Galvanic Skin Response; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008722:Methods; D010653:Phenylbutazone / Q000009:adverse effects; D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D012871:Skin Diseases / Q000139:chemically induced; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D013449:Sulfonamides / Q000009:adverse effects; D013997:Time Factors
D000962:Antimalarials; D011720:Pyrazoles; D013449:Sulfonamides; D010653:Phenylbutazone; D003078:Colchicine
Die Verwertbarkeit der elektrodermatometrischen Methode (Wohlstein) bei der Behandlung mit Pyrazolonderivaten.